新兴的生物标志物和分子标用于宫癌的精密医学
Pankaj Garg1, Madhu Krishna2, Ayalur Raghu Subbalakshmi2
1Department of Chemistry, GLA University, Mathura, Uttar Pradesh 281406, India.
Biochimica et biophysica acta. Reviews on cancer
|May 3, 2024
概括
新的生物标志物和分子标正在彻底改变宫癌的治疗. 精准医学提供量身定制的诊断和治疗方法,改善患者的治疗结果并改变疾病管理.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 宫癌是一个重大的全球健康挑战.
- 创新的诊断和治疗策略对于改善患者治疗结果至关重要.
- 精准医学为癌症治疗提供了个性化的方法.
研究的目的:
- 审查宫癌中的新兴生物标志物和分子标.
- 为了突出它们对精准医学的影响.
- 讨论它们在早期检测和向治疗开发中的作用.
主要方法:
- 关于宫癌生物标志物的最近研究的文献综述.
- 对涉及宫癌发生的分子标进行分析.
- 探索整合新生物标记物的诊断算法.
主要成果:
- 新兴的生物标志物可以帮助早期识别高风险患者.
- 特定的分子标使得开发有针对性的疗法成为可能.
- 生物标志物的整合提高了诊断准确性和治疗选择.
结论:
- 生物标志物和分子标是推动子宫癌精准医学发展的关键.
- 个性化治疗策略可以显著改善患者的治疗结果.
- 这些进展有望改变宫癌的治疗方法.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K